These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38928187)

  • 21. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
    Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH
    World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma.
    Köberle V; Kronenberger B; Pleli T; Trojan J; Imelmann E; Peveling-Oberhag J; Welker MW; Elhendawy M; Zeuzem S; Piiper A; Waidmann O
    Eur J Cancer; 2013 Nov; 49(16):3442-9. PubMed ID: 23810247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma.
    Li J; Jin B; Wang T; Li W; Wang Z; Zhang H; Song Y; Li N
    Cancer Biomark; 2019; 26(4):501-512. PubMed ID: 31658041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
    Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly Sensitive Serum miRNA Panel for the Diagnosis of Hepatocellular Carcinoma in Egyptian Patients with HCV-Related HCC.
    Yosry A; Zayed N; Dawood RM; Ibrahim MK; Elsharkawy M; Ekladious SM; Khairy A; Elsharkawy A; Khairy M; Abdel Alem S; Bader El Din NG; El Awady MK; Abdellatif Z
    Lab Med; 2022 Sep; 53(5):523-529. PubMed ID: 35731638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APSA Awardee Submission: Tumor/cancer stem cell marker doublecortin-like kinase 1 in liver diseases.
    Nguyen CB; Houchen CW; Ali N
    Exp Biol Med (Maywood); 2017 Feb; 242(3):242-249. PubMed ID: 27694285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma.
    Dhayat SA; Hüsing A; Senninger N; Schmidt HH; Haier J; Wolters H; Kabar I
    PLoS One; 2015; 10(10):e0140066. PubMed ID: 26447841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive transcriptomic analyses of tissue, serum, and serum exosomes from hepatocellular carcinoma patients.
    Mjelle R; Dima SO; Bacalbasa N; Chawla K; Sorop A; Cucu D; Herlea V; Sætrom P; Popescu I
    BMC Cancer; 2019 Oct; 19(1):1007. PubMed ID: 31660891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-876 Inhibits EMT and Liver Fibrosis via POSTN to Suppress Metastasis in Hepatocellular Carcinoma.
    Chen K; Li Z; Zhang M; Wang B; Peng T; Shen Y; Zhang J; Ye J; Liu Y; Tang D; Peng M; Ma D; Xiao Z; Zhang Y; Jin W; Li X
    Biomed Res Int; 2020; 2020():1964219. PubMed ID: 33083453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function.
    Okajima W; Komatsu S; Ichikawa D; Miyamae M; Kawaguchi T; Hirajima S; Ohashi T; Imamura T; Kiuchi J; Arita T; Konishi H; Shiozaki A; Moriumura R; Ikoma H; Okamoto K; Taniguchi H; Itoh Y; Otsuji E
    Oncotarget; 2016 Aug; 7(33):53820-53836. PubMed ID: 27462777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Impact of Circulated miR-1291 in Plasma of Patients with Liver Cirrhosis (LC) and Hepatocellular Carcinoma (HCC): Implication on Glypican-3 Expression.
    Hagag NA; Ali YBM; Elsharawy AA; Talaat RM
    J Gastrointest Cancer; 2020 Mar; 51(1):234-241. PubMed ID: 31028536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
    Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection.
    Qi P; Cheng SQ; Wang H; Li N; Chen YF; Gao CF
    PLoS One; 2011; 6(12):e28486. PubMed ID: 22174818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma.
    Oksuz Z; Serin MS; Kaplan E; Dogen A; Tezcan S; Aslan G; Emekdas G; Sezgin O; Altintas E; Tiftik EN
    Mol Biol Rep; 2015 Mar; 42(3):713-20. PubMed ID: 25391771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma.
    Chen Y; Chen J; Liu Y; Li S; Huang P
    Med Sci Monit; 2015 Jun; 21():1864-71. PubMed ID: 26119771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-424 inhibits cell migration, invasion, and epithelial mesenchymal transition by downregulating doublecortin-like kinase 1 in ovarian clear cell carcinoma.
    Wu X; Ruan Y; Jiang H; Xu C
    Int J Biochem Cell Biol; 2017 Apr; 85():66-74. PubMed ID: 28161486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression Analysis of Serum microRNA-34a and microRNA-183 in Hepatocellular Carcinoma.
    Bharali D; Jebur HB; Baishya D; Kumar S; Sarma MP; Masroor M; Akhter J; Husain SA; Kar P
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2561-2568. PubMed ID: 30256056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of Sensitivity to Chemo/Radiation Therapy by Using miR-15b against DCLK1 in Colorectal Cancer.
    Ji D; Zhan T; Li M; Yao Y; Jia J; Yi H; Qiao M; Xia J; Zhang Z; Ding H; Song C; Han Y; Gu J
    Stem Cell Reports; 2018 Dec; 11(6):1506-1522. PubMed ID: 30449704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 and Promotes Tumorigenesis in Mice.
    Dandawate P; Ghosh C; Palaniyandi K; Paul S; Rawal S; Pradhan R; Sayed AAA; Choudhury S; Standing D; Subramaniam D; Padhye SB; Gunewardena S; Thomas SM; Neil MO; Tawfik O; Welch DR; Jensen RA; Maliski S; Weir S; Iwakuma T; Anant S; Dhar A
    Gastroenterology; 2019 Dec; 157(6):1646-1659.e11. PubMed ID: 31442435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-579-3p Controls Hepatocellular Carcinoma Formation by Regulating the Phosphoinositide 3-Kinase-Protein Kinase B Pathway in Chronically Inflamed Liver.
    Quintavalle C; Meyer-Schaller N; Roessler S; Calabrese D; Marone R; Riedl T; Picco-Rey S; Panagiotou OA; Uzun S; Piscuoglio S; Boldanova T; Bian CB; Semela D; Jochum W; Cathomas G; Mertz KD; Diebold J; Mazzucchelli L; Koelzer VH; Weber A; Decaens T; Terracciano LM; Heikenwalder M; Hoshida Y; Andersen JB; Thorgeirsson SS; Matter MS
    Hepatol Commun; 2022 Jun; 6(6):1467-1481. PubMed ID: 35132819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.